Equine HSP90α antibody and antigen (recombinant protein)
Diagnostic anti-Equine HSP90α antibodies pairs and antigen for animal health (animal Equine/Horse renal cancer, liver cancer and breast cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-HSP90a-Ag01 | Equine HSP90α | $3090.00 |
GMP-EQU-HSP90a-Ab01 | Anti-Equine HSP90α mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-HSP90a-Ab02 | Anti-Equine HSP90α mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-HSP90a-Ab03 | Anti-Equine HSP90α human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-HSP90a-Ab04 | Anti-Equine HSP90α human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-HSP90a-Ag01 |
Product Name | Equine HSP90α |
Target/Biomarker | Equine HSP90α |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine HSP90α antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of animal Equine/Horse with renal cancer, liver cancer and breast cancer. |
Tag | His | Reconized/Reactive Specics | Equine HSP90α |
Product description | Recombinant Equine HSP90α protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-HSP90a-Ab01,GMP-EQU-HSP90a-Ab02 |
Target/Biomarker | Equine HSP90α |
Product Name | Anti-Equine HSP90α mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine HSP90α antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine HSP90α antibodies in Equine HSP90α level test of animal Equine/Horse with renal cancer, liver cancer and breast cancer. |
Product description | Anti-Equine HSP90α mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine HSP90α antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-HSP90a-Ab03,GMP-EQU-HSP90a-Ab04 |
Target/Biomarker | Equine HSP90α |
Product Name | Anti-Equine HSP90α human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine HSP90α antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine HSP90α antibodies in Equine HSP90α level test of animal Equine/Horse with renal cancer, liver cancer and breast cancer. |
Product description | Anti-Equine HSP90α mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
HSP90α, or Heat Shock Protein 90 alpha, is a biomarker of significant importance within the realm of horses (equines). It belongs to the heat shock protein family, a group of molecular chaperones that play essential roles in maintaining cellular health and protein quality control. HSP90α, specifically, is predominantly localized within the cytoplasm of equine cells, where it carries out crucial functions related to protein folding, stabilization, and cellular response to stress.
One of the primary roles of HSP90α is to act as a molecular chaperone, assisting in the proper folding of newly synthesized proteins. This process is essential to ensure that proteins adopt their correct three-dimensional structures, allowing them to function optimally. Moreover, HSP90α plays a role in refolding and repairing damaged or misfolded proteins. This function is particularly critical when cells face stressors that can cause proteins to misfold or aggregate, such as elevated temperatures, infections, toxins, or other environmental challenges.
In response to various forms of cellular stress, the expression of HSP90α in equine cells increases significantly. This upregulation is part of the cell's adaptive response mechanism aimed at preserving protein integrity and preventing cellular dysfunction. By assisting in protein folding and repair, HSP90α helps cells cope with stress and maintain their essential functions.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.